Epoch Investment Partners Inc. Sells 291 Shares of Revvity, Inc. (NYSE:RVTY)

Epoch Investment Partners Inc. lowered its stake in Revvity, Inc. (NYSE:RVTY) by 12.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,021 shares of the company’s stock after selling 291 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Revvity were worth $212,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of RVTY. Capital Research Global Investors bought a new stake in shares of Revvity in the 4th quarter valued at $838,080,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Revvity in the 4th quarter valued at $188,368,000. Norges Bank bought a new stake in shares of Revvity in the 4th quarter valued at $129,483,000. Northern Trust Corp bought a new stake in shares of Revvity in the 4th quarter valued at $127,401,000. Finally, Dimensional Fund Advisors LP bought a new stake in shares of Revvity in the 4th quarter valued at $112,037,000. Institutional investors own 86.65% of the company’s stock.

Insider Buying and Selling

In related news, insider Joel S. Goldberg sold 4,000 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $110.46, for a total value of $441,840.00. Following the transaction, the insider now directly owns 36,900 shares of the company’s stock, valued at approximately $4,075,974. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on RVTY shares. Robert W. Baird lifted their price objective on shares of Revvity from $126.00 to $127.00 and gave the company an “outperform” rating in a research note on Tuesday, April 30th. Leerink Partnrs raised shares of Revvity to a “strong-buy” rating in a research report on Monday, July 8th. Barclays reduced their price target on shares of Revvity from $116.00 to $115.00 and set an “equal weight” rating for the company in a research report on Friday, June 28th. Jefferies Financial Group started coverage on shares of Revvity in a research report on Monday, June 3rd. They issued a “hold” rating and a $115.00 price target for the company. Finally, SVB Leerink started coverage on shares of Revvity in a research report on Monday, July 8th. They issued an “outperform” rating and a $125.00 price target for the company. Seven investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $119.14.

Revvity Stock Performance

Shares of NYSE:RVTY traded up $2.34 during midday trading on Friday, reaching $115.15. The company had a trading volume of 1,384,132 shares, compared to its average volume of 833,285. The company’s 50 day moving average price is $108.82 and its 200 day moving average price is $106.50. The company has a current ratio of 2.23, a quick ratio of 1.92 and a debt-to-equity ratio of 0.40. The stock has a market cap of $14.21 billion, a P/E ratio of 95.17, a P/E/G ratio of 3.00 and a beta of 1.05. Revvity, Inc. has a 52-week low of $79.50 and a 52-week high of $131.96.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.04. The company had revenue of $649.90 million for the quarter, compared to the consensus estimate of $646.83 million. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The firm’s quarterly revenue was down 3.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.01 EPS. As a group, sell-side analysts anticipate that Revvity, Inc. will post 4.64 EPS for the current fiscal year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date is Friday, October 18th. Revvity’s dividend payout ratio (DPR) is currently 23.14%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.